Lv1
36 积分 2025-09-25 加入
Metabolic heterogeneity, networks, and biomarkers of drug-induced liver injury
1天前
待确认
Zongertinib: First Approval
1天前
求助中
Zongertinib: First Approval
2天前
已关闭
Trastuzumab Rezetecan: First Approval
3天前
已完结
Zongertinib: First Approval
3天前
已关闭
Immunotherapy for extensive-stage small cell lung cancer: current status, challenges and future strategies
6天前
已完结
Cracking the Code of Immunotherapy Resistance in SCLC: Molecular Insights and Emerging Solutions
6天前
已完结
Undetectable pre‐radical cystectomy circulating tumour DNA status predicts improved oncological outcomes
1个月前
已完结
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer
1个月前
已完结
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial
1个月前
已完结
皖公网安备34019202002308
